…R., BIRK, R., BREALEY, N., ISMAILA, A. S., ZHU, C. Q. & LIPSON, D. A. 2018. Single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol plus umeclidinium using two inhalers for chronic obstructive…
…M., DENNIS, R. J. & KARNER, C. 2016. Combination inhaled steroid and long-acting beta(2)-agonist in addition to tiotropium versus tiotropium or combination alone for chronic obstructive pulmonary disease. Cochrane Database…
The COPD-X Plan: Australian and New Zealand Guidelines for the Management of Chronic Obstructive Pulmonary Disease 2024 COPD-X Version 2.75 (June 2024) PDF download Lung Foundation Australia’s COPD-X Guidelines Committee…
…C., MOLINS, E., CARACTA, C., GIL, E. G. & LESELBAUM, A. 2014b. Efficacy and safety of aclidinium bromide/formoterol fumarate fixed-dose combinations compared with individual components and placebo in patients with…
…COPD-X V2.63 June 2021 These PDF are searchable documents. Download the document/s. Enter your search term in the Find box located on the Toolbar after download. For COPD-X Plan…
…with single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) had significantly better adherence (46.5% vs. 22.3%; RR 2.08, 95% CI 1.85–2.30) and persistence (35.7% vs. 13.9%; HR 1.91, 95% CI 1.81–2.01, p<0.001) compared with…
…more comorbidities, compared to 7% with no comorbidities (Skajaa 2023). A population-based cohort study in Ontario, Canada using linked datasets and including all patients aged 35 years or older living…
…Obstructive Pulmonary Disease 2003. MJA 2003 178(6 Suppl 17 Mar): S1-S40 www.mja.com.au/public/issues/178_06_170303/tho10508_all.html Clinical Practice Update Michael J Abramson, Alan J Crockett, Peter A Frith and Christine F McDonald. COPDX: an…
…on the Internet http://www.lungnet.com.au (now http://www.lungfoundation.com.au) and access to them was advertised in a national newspaper. The draft guidelines were circulated to all members of the TSANZ and Australian Divisions…